Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 1004-1009

  De Vos, Piet ^a   Lefebvre, Anne Marie ^a   Miller, Stephen G ^b   Guerre Millo, Michele ^c   Wong, Kenneth ^b   Saladin, Regis ^a   Hamann, Lawrence G ^b   Staels, Bart ^a   Briggs, Michael R ^b   Auwerx, Johan ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LIGAND PHARMACEUTICALS INC   (United States)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

adipocyte; adipose; antidiabetic; obesity

Indexed keywords

FENOFIBRATE; GENE PRODUCT; GLUCOCORTICOID; INSULIN; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE;

ADIPOCYTE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; ENERGY BALANCE; GENE EXPRESSION REGULATION; GENE REPRESSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

EID: 0000113890     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118860     Document Type: Article

References (61)

1. Grundy, S.M., and J.P. Barnett. 1990. Metabolic and health complications of obesity. Disease-a-Month. 36:641-731.
2. Friedman, J.M., and R.L. Leibel. 1990. Tackling a weighty problem. Cell. 69:217-220.
3. Friedman, J.M., R.L. Leibel, D.S. Siegel, J. Walsh, and N. Bahary. 1991. Molecular mapping of the mouse ob mutation. Genomics. 11:1054-1062.
4. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homolog. Nature (Lond.). 372:425-432.
5. Halaas, J.L., K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, D. Rabinowitz, R.L. Lallone, S.K. Burley, and J.M. Friedman. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science (Wash. DC). 269:543-546.
6. Coleman, D.L. 1978. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 14:141-148.
7. Campfield, L.A., F.J. Smith, Y. Guisez, R. Devos, and P. Burn. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science (Wash. DC). 269:546-549.
8. Pelleymounter, M.A., M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. 1995. Effect of the obese gene product on body weight regulation in ob/ob mice. Science (Wash. DC). 269:540-543.
9. Weigle, D.S., T.R. Bukowski, D.C. Foster, S. Holderman, J.M. Kramer, G. Lasser, C.E. Lofton-Day, D.E. Prunkard, C. Raymond, and J.L. Kuijper. 1995. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96:2065-2070.
10. Rentsch, J., N. Levens, and M. Chiesi. 1995. Recombinant ob gene product reduces food intake in fasted mice. Biochem. Biophys. Res. Commun. 214: 131-136.
11. Tartaglia, L.A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G.J. Richards, L.A. Campfield, F.T. Clark, J. Deeds, et al. 1995. Identification and expression cloning of a leptin receptor. OB-R. Cell. 83:1263-1271.
12. Lee, G.H., R. Proenca, J.M. Montez, K.M. Carroll, J.G. Darvishzadeh, J.I. Lee, and J.M. Friedman. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature (Lond.). 379:632-635.
13. Frederich, R.C., B. Lollmann, A. Hamann, A. Napolitano-Rosen, B.B. Kahn, B.B. Lowell, and J.S. Flier. 1995. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96: 1658-1663.
14. MacDougald, O.A., C.S. Hwang, H. Fan, and M.D. Lane. 1995. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA. 92:9034-9037.
15. Trayhurn, P., M.E.A. Thomas, J.S. Duncan, and V.D. Rayner. 1995. Effect of fasting and refeeding on ob gene expression in white adipose tissue of lean and (ob/ob) mice. FEBS Lett. 368:488-490.
16. Saladin, R., P. De Vos, M. Guerre-Millo, A. Leturque, J. Girard, B. Staels, and J. Auwerx. 1995. Transient increase in obese gene expression after food intake and insulin administration. Nature (Lond.). 377:527-529.
17. De Vos, P., R. Saladin, J. Auwerx, and B. Staels. 1995. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270:15958-15961.
18. Murakami, T., M. Iida, and K. Shima. 1995. Dexamethasone regulates obese expressioin in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 214:1260-1267.
19. Considine, R.V., E.L. Considine, C.J. Williams, M.R. Nyce, S.A. Magosin, T.L. Bauer, E.L. Rosato, J. Colberg, and J.F. Caro. 1995. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95:2986-2988.
20. Lönnqvist, F., P. Arner, L. Nordfors, and M. Schalling. 1995. Overexpressioin of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med. 1:950-953.
21. Hamilton, B.S., D. Ivaglia, A.Y.M. Kwan, and M. Deitel. 1995. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat. Med. 1:954-956.
22. Maffei, M., J. Halaas, E. Ravussin, R.E. Pratley, G.H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, et al. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1155-1161.
23. Considine, R.V., M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, and J.F. Caro. 1996. Serum-immunoreactive leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295.
24. Murakami, T., and K. Shima. 1995. Cloning of rat obese cDNA and its expression in obese rats. Biochem. Biophys. Res. Commun. 209:944-952.
25. Funahashi, T., I. Shimomura, H. Hiraoka, T. Arai, M. Takahashi, T. Nakamura, S. Nozaki, S. Yamashita, K. Takemura, K. Tokunuga, and Y. Matsuzawa. 1995. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem. Biophys. Res. Commun. 211:469-475.
26. Ogawa, Y., H. Masuzaki, N. Isse, T. Okazaki, K. Mori, M. Shigemoto, N. Satoh, N. Tamura, K. Hosoda, Y. Yoshimasa, et al. 1995. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J. Clin. Invest. 96:1647-1652.
27. Maffei, M., H. Fei, G.-H. Lee, C. Dani, P. Leroy, Y. Zhang, R. Proenica, R. Negrel, G. Ailhaud, and J.M. Friedman. 1995. Increased expression in adipocytes of ob RNA in mice with lesions of hypothalamus and with mutations in the db locus. Proc. Nat. Acad. Sci. USA. 92:6957-6960.
28. Masuzaki, H., K. Hosoda, Y. Ogawa, M. Shigemoto, N. Satoh, K. Mori, N. Tamura, S. Nishi, Y. Yoshimas, Y. Yamori, and K. Nakao. 1996. Augmented expression of obese (ob) gene during the process of obesity in genetically obese-hyperglycemic Wistar (fa/fa) rats. FEBS Lett. 378:267-271.
29. Schoonjans, K., B. Staels, and J. Auwerx. 1996. Role of the peroxisome proliferator activated receptor (PPAR) in mediating effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:907-925.
30. Miller, S.G., P. De Vos, M. Guerre-Millo, K. Wong, T. Hermann, B. Staels, M.R. Briggs, and J. Auwerx. 1996. The adipocyte-specific transcription. C/EBPα modulates human ob gene expression. Proc. Nat. Acad. Sci. USA. 93: 5507-5511.
31. He, Y., H. Chen, M.J. Quon, and M. Reitman. 1995. The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J. Biol. Chem. 270:28887-28891.
32. Hajduch, E.J., M. Guerre-Millo, I.A. Hainault, C.M. Guichard, and M.M. Lavau. 1992. Expression of glucose transporters (GLUT1 and GLUT4) in primary cultured rat adipocytes: differential evolution with time and chronic insulin effect. J. Cell. Biochem. 49:251-258.
33. Cleveland, D.W., M.A. Lopata, R.J. McDonald, M.J. Cowan, W.J. Rutter, and M.W. Kirschner. 1980. Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell. 20:95-105.
34. Henikoff, S. 1984. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene. 28:351-359.
35. Aperio, C., P. Pognonec, R. Saladin, J. Auwerx, and K. Boulukos. 1995. Isolation and characterization of the hamster peroxisomal proliferator activated receptor hPPARγ, a member of the nuclear hormone receptor superfamily. Gene. 162:297-302.
36. Schoonjans, K., M. Watanabe, H. Suzuki, A. Mahfoudi, G. Krey, W. Wahli, P. Grimaldi, B. Staels, T. Yamamoto, and J. Auwerx. 1995. Induction of the Acyl-Coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270:19269-19276.
37. Quon, M.J., M.J. Zarnowski, M. Guerre-Millo, M. Luz Sierra, S.I. Taylor, and S.W. Cushman. 1993. Transfection of DNA into isolated rat adipose cells by electroporation. Biochem. Biophys. Res. Commun. 194:338-346.
38. Tontonoz, P., E. Hu. and B.M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell. 79: 1147-1156.
39. Tontonoz, P., E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman. 1994. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes & Dev. 8:1224-1234.
40. Darlington, G.J., N. Wang, and R.W. Hanson. 1995. C/EBPα: a critical regulator of genes governing metabolic processes. Curr. Opin. Genet. & Dev. 5: 565-570.
41. Lehmann, J., L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ) J. Biol. Chem. 270:12953-12956.
42. Forman, B.M., P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans. 1995. 15-Deoxy-Δ12,14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell. 83:803-812.
43. Hiragun, A., M. Sato, and H. Mitsui. 1988. Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent. J. Cell. Physiol. 134: 124-130.
44. Sparks, R.L., E.E. Strauss, A.I. Zygmunt, and T.E. Phelan. 1991. Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells. J. Cell. Physiol. 146:101-109.
45. Kletzien, R.F., S.D. Clarke, and R.G. Ulrich. 1992. Enhancement of adipocyte differentiation by an insulin sensitizing agent. Mol. Pharmacol. 41:393-398.
46. Sandouk, T., D. Reda, and C. Hofmann. 1993. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol. 264:C1600-C1608.
47. Tehoul, L., D. Gaillard, L. Staccini, H. Inadera, E.Z. Amri, and P. Grimaldi. 1995. Thiaxolidinediones and fatty acids convert myogenic cells into adipose-like cells. J. Biol. Chem. 270:28137-28183.
48. Staels, B., A. Van Tol, T. Andreu, and J. Auwerx. 1992. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler. Thromb. 12:286-294.
49. Staels, B., N. Vu-Dac, V. Kosykh, R. Saladin, J.C. Fruchart, J. Dallongeville, and J. Auwerx. 1995. Fibrates down-regulate apolipoprotein C-III expression independent of induction of peroxisomal Acyl coenzyme A oxidase. J. Clin. Invest. 95:705-712.
50. Tontonoz, P., E. Hu, J. Devine, E.G., Beale, and B.M. Spiegelman. 1995. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15:351-357.
51. Schoonjans, K., B. Staels, P. Grimaldi, and J. Auwerx. 1993. Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. Eur. J. Biochem. 216:615-622.
52. Kliewer, S.A., J.M. Lenhard, T.M. Willson, I. Patel, D.C. Morris, and J.M. Lehman. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 83:813-819.
53. Amri, E.-Z., B. Bertrand, G. Ailhaud, and P. Grimaldi. 1991. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J. Lipid Res. 32:1449-1456.
54. Chawla, A., and M.A. Lazar. 1994. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc. Natl. Acad. Sci. USA. 91:1786-1790.
55. Gaillard, D., R. Negre, M. Lagarde, and G. Ailhaud. 1989. Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem. J. 257:389-397.
56. Hertz, R., J. Bishara-Shieban, and J. Bar-Tana. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs, suppression of apolipoprotein C-III. J. Biol. Chem. 270:13470-13475.
57. Ikeda, H., S. Taketomi, Y. Sugiyama, Y. Shimura, T. Sohda, K. Meguro, and T. Fujita. 1990. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Drug Res. 40:156-162.
58. Castle, C.K., J.R. Colca, and G.W. Melchior. 1993. Lipoprotein profile characterization of the KKAy mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone. Arterioscler. Thromb. 13:302-309.
59. Hirshman, M.F., P.M. Fagnant, E.D. Horton, P.A. King, and E.S. Horton. 1995. Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes. Biochem. Biophys. Res. Commun. 208:835-845.
60. Blundell, J.E., V.J. Burley, J.R. Cotton, and C.L. Lawton. 1993. Dietary-fat and the control of energy intake: evaluating the effects of fat on meal size and postmeal satiety. Am. J. Clin. Nutr. 57:772-778.
61. Rolls, B.J., S. Kim-Harris, M.W. Fischman, R.W. Foltin, T.H. Moran, and S.A. Stoner. 1994. Satiety after preloads with different amounts of fat and carbohydrate: implications for obesity. Am. J. Clin. Nutr. 60:476-487.